Cumberland Pharmaceuticals Inc. Income Taxes Paid
Cumberland Pharmaceuticals Inc. (CPIX) reported Income Taxes Paid of -$3.52 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-03-09
- Cumberland Pharmaceuticals Inc. income taxes paid, net for fiscal 2025 was -$3.52K, a 123.50% decline from fiscal 2024.
- Cumberland Pharmaceuticals Inc. income taxes paid, net for fiscal 2024 was $15.00K, a 86.22% decline from fiscal 2023.
- Cumberland Pharmaceuticals Inc. income taxes paid, net for fiscal 2023 was $108.82K, a 3197.67% increase from fiscal 2022.
- Cumberland Pharmaceuticals Inc. income taxes paid, net for fiscal 2022 was $3.30K.
| Period end | Income Taxes Paid, Net 12 month |
|---|---|
| 2025-12-31 | -$3.52K 10-K · filed 2026-03-09 |
| 2024-12-31 | $15.00K 10-K · filed 2026-03-09 |
| 2023-12-31 | $108.82K 10-K · filed 2025-03-07 |
| 2022-12-31 | $3.30K 10-K · filed 2024-03-13 |
| 2021-12-31 | -$327.00 10-K · filed 2023-03-13 |
| 2020-12-31 | -$91.49K 10-K · filed 2022-03-11 |
| 2019-12-31 | $16.69K 10-K · filed 2022-03-11 |
| 2018-12-31 | $15.44K 10-K · filed 2021-03-12 |
| 2017-12-31 | $18.00K 8-K · filed 2020-12-10 |
| 2016-12-31 | -$8.36K 10-K · filed 2019-03-12 |
| 2015-12-31 | $52.24K 10-K · filed 2018-03-09 |
| 2014-12-31 | $17.08K 10-K · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |